Skip to content

Sucralose, Stevia, Gut Microbiome and Glucose Metabolism

Sucralose, Stevia, Gut Microbiome and Glucose Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02800707
Enrollment
40
Registered
2016-06-15
Start date
2017-01-03
Completion date
2018-01-31
Last updated
2018-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Glucose Tolerance

Brief summary

This study will determine the influence of two non-caloric sweeteners on glucose metabolism via the gut microbiome in adult men and women.

Detailed description

This study will determine the influence of two non-caloric sweeteners on glucose metabolism via the gut microbiome in adult men and women aged 35-55 years.

Interventions

OTHERSucralose

Sweetner

OTHERStevia

Sweetner

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Generally health adult men and women aged 35-55 years old -

Exclusion criteria

Adults will not be eligible who have chronic disease (cancer, CHD, diabetes, chronic kidney disease); pregnant or breast feeding; menopausal; has a history of bariatric surgery; taking prednisone/steroids, taking medication for PCOS, or take medications that influence blood glucose. \-

Design outcomes

Primary

MeasureTime frameDescription
2-hour glucose14 daysAn oral glucose tolerance test will be administered before and after consuming assigned sweetener to determine change in 2-hour glucose

Secondary

MeasureTime frameDescription
Gut microbiome14 daysGut microbiota will be measured before and after consuming assigned sweetener to determine change in gut microbiota.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026